Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 11.38% vs 5.74% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 162.50% vs 400.00% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 30.12% vs 15.09% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 6.34% vs -1.44% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Collegium Pharmaceutical, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 11.38% vs 5.74% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 31.45% vs 16.53% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 162.50% vs 400.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 238.71% vs -54.85% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 30.12% vs 15.09% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 24.46% vs 17.54% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 6.34% vs -1.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 18.48% vs -11.54% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






